STADAPHARM GmbH
Location
Hessen
Founded
1993-02-24
Website
Risk Signals
672 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, In Vitro and In Vivo Diagnostic Substances, Patent Owners and Lessors, Business Services, Not Elsewhere Classified, Engineering Services, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about STADAPHARM GmbH
Live alerts from global media, monitored by Business Radar
2025-09-01 (ffh.de)
But no IPO - investor takes over Stada
A few days ago, Stada started one of the largest IPO this year. But now a new investor has been found for the company
Read more2025-09-01 (hessenschau.de)
Stada stock market comeback finally blown out | | Business
Stocking yes, stock exchange no, stock exchange yes - and now? The Bad Vilbeler drug manufacturer has now finally canceled the planned comeback in securities trading. A British investor takes over the majority of the group.
Read more
2025-08-29 (wallstreet-online.de)
Dax & Co: IPO boom, reforms & good momentum-finally swing in Frankfurt?
Page 1 of the discussion 'Dax & Co: IPO boom, reforms & good momentum-finally swing in Frankfurt?' from 29.08.2025 in the Wo-Forum 'Dax'.
Read more2025-08-28 (boersennews.de)
Companies from 28.08.2025 - 3:15 p.m. 28.08.2025, 3:20 p.m. from DPA -AFX Comment now: 0
Nvidia wants billions from China, Delivery Hero surprises positively, PPF secures the majority of ProSiebenSat.1, Pernod Ricard burdened, Qiagen plans to be convertible bonds, Stada Plant IPO
Read more2025-08-28 (finance-magazin.de)
Stada prepares comeback on the stock exchange -
The private equity investors Bain Capital and Cinven now want to bring Stada to the stock exchange. The exit has been going on for over two years.
Read more2025-08-28 (fr.de)
Done because of Trump: Hessian medicinal giant takes a new start for the IPO
After a failed attempt in April, pharmaceutical manufacturer Stada dared to take a new IPO in autumn. The evaluation could be ten billion euros.
Read more2025-08-28 (badische-zeitung.de)
Stada is preparing a billion -dollar exchange in autumn - economy -
The first attempt failed due to Trump's customs duties, now the pharmaceutical company is taking a new attempt. Stada boss Goldschmidt relies on a stable environment - and sees an advantage.
Read more2025-08-06 (finanznachrichten.de)
Stada: New IPO rumors - everything is going very quickly now?
As early as spring, the intentions to bring the generic manufacturer Stada to the stock exchange again. In March, the prospect of listening was canceled due to market uncertainties.
Read more2025-07-30 (juve-patent.com)
Showdown in Munich: Federal Patent Court revokes Xarelto patent -
After being granted PIs in both instances in Munich, the Federal Patent Court has now revoked one of Bayer's crucial xarelto patents.
Read more2025-07-17 (zwp-online.info)
Almost every second shows burnout symptoms: Austria's health under pressure-ZWP online-the news portal for the dental industry
Since 2014, the Stada Health Report has been investigating how people perceive health, talk about it and adapt their behavior accordingly. For the seventh time, the survey was carried out across borders and provides exciting insight into the health understanding of Europeans: especially in the subject areas mental health, preventive health measures, lifestyle, self -care and health system.
Read more2025-07-15 (zwp-online.info)
Only every second German leads a healthy life - ZWP online - the news portal for the dental industry
Stada Health Report 2025: Satisfaction with the German health system has stabilized. But only half of the respondents also think it is fair. And one of three Germans does not trust adequate treatment in the event of a serious illness.
Read more
2025-07-14 (pharma-relations.de)
Andreas Fibig becomes chairman of the Stada Board of Directors
The owners Cinven and Bain Capital set the course for the future of Stada at the turn of the year. There has been no decision yet ...
Read more